Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-06

Clinical Trial Update: Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 study of trabodenoson in adults with ocular hypertension or primary open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trabodenoson (trabodenoson)

Snippet

Sponsor: Inotek Pharmaceuticals Corporation | Conditions: Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 3 | Status: COMPLETED